Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics - PubMed (original) (raw)

Practice Guideline

Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics

Hania Szajewska et al. J Pediatr Gastroenterol Nutr. 2014 Apr.

Erratum in

J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):188

Abstract

The use of probiotics has been suggested in the treatment of acute gastroenteritis (AGE) in addition to early rehydration and avoidance of dietary restrictions. This document provides recommendations for the use of probiotics for the treatment of AGE in previously healthy infants and children based on a systematic review of previously completed systematic reviews and of randomized controlled trials (RCTs) published subsequently to these reviews. The recommendations were formulated only if at least 2 RCTs that used a given probiotic (with strain specification) were available. The GRADE system developed by the Grading of Recommendations, Assessment, Development, and Evaluations Working Group, was used to grade the strength of evidence and grades of recommendations used in these guidelines. It offers 4 categories of the quality of the evidence (high, moderate, low, and very low) and 2 categories of the strength of recommendation (strong or weak). The use of the following probiotics (in alphabetical order) may be considered in the management of children with AGE in addition to rehydration therapy: Lactobacillus rhamnosus GG (low quality of evidence, strong recommendation) and Saccharomyces boulardii (low quality of evidence, strong recommendation). Less compelling evidence is available for Lactobacillus reuteri DSM 17938 (very low quality of evidence, weak recommendation) and heat-inactivated Lactobacillus acidophilus LB (very low quality of evidence, weak recommendation). The latter, although traditionally discussed with other probiotics, does not fit with the definition of probiotics. Other strains or combinations of strains have been tested, but evidence of their efficacy is weak or preliminary.

PubMed Disclaimer

Comment in

Comment on the Safety of Enterococcus faecium SF68.
Verholen F, Schori B, Haering G. Verholen F, et al. J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):e12. doi: 10.1097/MPG.0000000000000937. J Pediatr Gastroenterol Nutr. 2016. PMID: 26252925 No abstract available.
Authors' Response.
Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, Vandenplas Y, Weizman Z. Szajewska H, et al. J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):e12-3. doi: 10.1097/MPG.0000000000000970. J Pediatr Gastroenterol Nutr. 2016. PMID: 26334257 No abstract available.

Cited by

Pilot study for the understanding and use of probiotics by different paediatric healthcare professionals working in different European countries.
Pettoello-Mantovani M, Çullu Çokuğraş F, Vural M, Mestrovic J, Nigri L, Piazzolla R, Giardino I, Conoscitore M, Namazova-Baranova L. Pettoello-Mantovani M, et al. Ital J Pediatr. 2019 May 3;45(1):57. doi: 10.1186/s13052-019-0648-4. Ital J Pediatr. 2019. PMID: 31053146 Free PMC article.
Probiotics in Children: What Is the Evidence?
Hojsak I. Hojsak I. Pediatr Gastroenterol Hepatol Nutr. 2017 Sep;20(3):139-146. doi: 10.5223/pghn.2017.20.3.139. Epub 2017 Sep 26. Pediatr Gastroenterol Hepatol Nutr. 2017. PMID: 29026729 Free PMC article. Review.
Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology.
Lee YY, Leow AH, Chai PF, Raja Ali RA, Lee WS, Goh KL. Lee YY, et al. JGH Open. 2020 Dec 12;5(1):11-19. doi: 10.1002/jgh3.12469. eCollection 2021 Jan. JGH Open. 2020. PMID: 33490608 Free PMC article. Review.
Do Your Kids Get What You Paid for? Evaluation of Commercially Available Probiotic Products Intended for Children in the Republic of the Philippines and the Republic of Korea.
Dioso CM, Vital P, Arellano K, Park H, Todorov SD, Ji Y, Holzapfel W. Dioso CM, et al. Foods. 2020 Sep 3;9(9):1229. doi: 10.3390/foods9091229. Foods. 2020. PMID: 32899215 Free PMC article.
The Antimicrobial Effect of Various Single-Strain and Multi-Strain Probiotics, Dietary Supplements or Other Beneficial Microbes against Common Clinical Wound Pathogens.
Fijan S, Kocbek P, Steyer A, Vodičar PM, Strauss M. Fijan S, et al. Microorganisms. 2022 Dec 19;10(12):2518. doi: 10.3390/microorganisms10122518. Microorganisms. 2022. PMID: 36557771 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics - PubMed (original) (raw)